E. Grigoriadou

发表

Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk

P. Ioannidis, R. Lagoudaki, N. Grigoriadis, 2020, Neurological research.

Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate

R. Lagoudaki, N. Grigoriadis, M. Boziki, 2019, Journal of the Neurological Sciences.

Effect of age and sex on craniomandibular disorders.

P. Koidis, P. Garefis, E. Grigoriadou, 1993, The Journal of prosthetic dentistry.

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study

P. Ioannidis, G. Hadjigeorgiou, D. Langdon, 2018, Journal of the Neurological Sciences.

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database

D. Tsalikakis, N. Grigoriadis, T. Moysiadis, 2020, Frontiers in Neurology.

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination

P. Bamidis, L. Probert, C. Styliadis, 2021, Frontiers in Neurology.

Effectiveness of conservative treatment for craniomandibular disorders: a 2-year longitudinal study.

P. Koidis, P. Garefis, E. Grigoriadou, 1994, Journal of orofacial pain.

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece

N. Grigoriadis, E. Kesidou, E. Thireos, 2023, Journal of clinical medicine.

Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece.

N. Grigoriadis, T. Moysiadis, E. Kesidou, 2023, International journal of MS care.